Standard Lipid-Lowering Therapy

DRUG3 trials

Sponsors

Hanyang University Seoul Hospital, Shanghai Zhongshan Hospital, West China Hospital

Conditions

Acute Myocardial Infarction (AMI)CoronaryCoronary Artery Disease

Phase 4

Single Dose PCSK9 Inhibitor to Improve Cardiovascular Outcomes After PCI: A Pilot Study

Not yet recruitingNCT07084259

Hanyang University Seoul HospitalCoronary Artery Disease

Start: 2025-07-31End: 2030-07-31Target: 352Updated: 2025-07-24

CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS

RecruitingNCT07612774

West China HospitalCoronary, Coronary Artery Disease

Start: 2025-11-19End: 2029-12-31Target: 232Updated: 2026-10-07

Unknown Phase

Very Early PCSK9 Inhibition for Acute Myocardial Infarction

RecruitingNCT07208006

Shanghai Zhongshan HospitalAcute Myocardial Infarction (AMI)

Start: 2026-01-01End: 2028-10-31Target: 1518Updated: 2026-01-27

Related Papers

Proactive, short-term PCSK9 inhibition after PCI in patients with coronary artery disease at high residual risk: rationale and design of the randomized HANYANG-PICK trial

Frontiers in Cardiovascular Medicine2026-03-02